Safe use of infliximab for the treatment of severe perianal Crohn’s disease after diagnosis and treatment of lymphoma
Crossref DOI link: https://doi.org/10.1007/s12328-017-0802-8
Published Online: 2017-11-22
Published Print: 2018-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bernardes, Carlos http://orcid.org/0000-0003-0567-9780
Russo, Pedro
Carvalho, Diana
Saiote, Joana
Ramos, Jaime
License valid from 2017-11-22